The Impact of Genomics on Public Health Practice: The Case for Change

Foundation for Genomics and Population Health, 2 Worts Causeway, Cambridge, UK.
Public Health Genomics (Impact Factor: 2.21). 04/2012; 15(3-4):118-24. DOI: 10.1159/000334840
Source: PubMed


Public health practice will not be able in the 21st century to ignore the impact of genomics, cell and molecular biology. It will need to take into consideration issues that include, among others: the complementary nature of social and biological models of disease, genetic exceptionalism, the readiness of public and patient to respond to genomic information, the relationship between individuals and populations, and concepts of population stratification. Health systems will need to adapt their practice and organisation to include new sequencing technologies, bioinformatic expertise and proper evaluation of genetic and molecular tests. Links with the commercial sector will increase in importance. The impact on developing countries cannot be ignored and will require special attention.

Download full-text


Available from: Muin J Khoury, Sep 02, 2014
  • Source
    • "There is a renewed interest in capacity building as part of translational science to improve the health outcomes (Brand 2012; Hacker et al. 2012; Williams 2012; Zimmern and Khoury 2012), and as important tools for increasing the representation of minority populations in research (Gill et al. 2013; "
    [Show abstract] [Hide abstract]
    ABSTRACT: Achieving equitable minority representation in genomic biobanking is one of the most difficult challenges faced by researchers today. Capacity building-a framework for research that includes collaborations and on-going engagement-can be used to help researchers, clinicians and communities better understand the process, utility, and clinical application of genomic science. The purpose of this exploratory descriptive study was to examine factors that influence the decision to participate in genomic research, and identify essential components of capacity building with a community at risk of being under-represented in biobanks. Results of focus groups conducted in Central Harlem with 46 participants were analyzed by a collaborative team of community and academic investigators using content analysis and AtlisTi. Key themes identified were: (1) the potential contribution of biobanking to individual and community health, for example the effect of the environment on health, (2) the societal context of the science, such as DNA criminal databases and paternity testing, that may affect the decision to participate, and (3) the researchers' commitment to community health as an outcome of capacity building. These key factors can contribute to achieving equity in biobank participation, and guide genetic specialists in biobank planning and implementation.
    Journal of Genetic Counseling 09/2014; 24(3). DOI:10.1007/s10897-014-9768-6 · 2.24 Impact Factor
  • Source
    • "Without wishing to invoke ‘genetic exceptionalism’ (the view that genetic or genomic information is special and that genetic and genomic tests must therefore be treated differently and more strictly regulated than other types of medical information [14]), a valid ethical and pragmatic question that has not yet been tackled empirically is whether students are capable of making independent, informed choices or ‘informed decisions’ about whether or not to receive their personal genome sequence, which they may analyze and interpret as part of their genomics training. The study of informed decision-making is related to but distinct from that of informed consent. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Multiple laboratories now offer clinical whole genome sequencing (WGS). We anticipate WGS becoming routinely used in research and clinical practice. Many institutions are exploring how best to educate genetics and other professionals about WGS. Providing students on WGS courses with the option to analyze their own genome sequence is one strategy that might enhance students' engagement and motivation to learn about personal genomes. However, if this option is presented to students, it is vital they make informed decisions, do not feel pressured into analyzing their own genomes by their course directors or peers, and feel free to analyze a third-party genome if they prefer. We therefore developed a 26-hour introductory genomics course in part to help students make informed decisions about whether to receive personal WGS data in a subsequent advanced genomics course. In the advanced course, they had the option to receive their own personal genome data, or an anonymous genome, at no financial cost to them. Our primary aims were to examine whether students made informed decisions regarding analyzing their personal genomes, and whether there was evidence that the introductory course enabled the students to make a more informed decision. This was a longitudinal cohort study in which students (n = 19) completed questionnaires assessing their intentions, informed decision-making, attitudes and knowledge before (T1) and after (T2) the introductory course, and before the advanced course (T3). Informed decision-making was assessed using the Decisional Conflict Scale. At the start of the introductory course (T1), most (17/19) students intended to receive their personal WGS data in the subsequent course, but many expressed conflict around this decision. Decisional conflict decreased after the introductory course (T2) indicating increased informed decision-making, and did not change before the advanced course (T3). This suggests it was the introductory course content rather than simply time passing that had the effect. In the advanced course, all (19/19) students opted to receive their personal WGS data. No changes in technical knowledge of genomics were observed. Overall attitudes towards WGS were broadly positive. Providing students with intensive introductory education about WGS may help them make informed decisions about whether or not to work with their personal WGS data in the educational setting.
    Genome Medicine 12/2013; 5(12):113. DOI:10.1186/gm518 · 5.34 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Disease outbreak investigation is a key aspect of public health. Whole-genome sequencing of bacterial pathogen based on new generation high-throughput sequencing technologies has facilitated outbreak investigations recently. Whilst the approach has become more affordable and accessible to research and clinical laboratories, a system for adequate and efficient analyses of genome data in the context of bacterial outbreak investigations is missing. Methods: We performed a literature review of timely genomic investigations performed during the course of bacterial outbreaks that are based on new generation sequencing technologies. Currently available bioinformatics tools for genomic analyses are also reviewed here. Results: Genomic investigations in early stages of bacterial outbreaks have shown to provide timely information on evolutionary origin, transmission route, pathogenic potential, and resistance information of the outbreak strains and allow development of strain-specific typing methods. A systematic genomic analytical workflow is proposed here for the first time to facilitate efficient extraction of epidemiologically useful information from genome data of bacterial pathogens in future bacterial outbreak investigations. Conclusion: With the continuous reduction of genome sequencing cost and development of user-friendly analytical tools, it is expected that high-throughput genome sequencing will be applied routinely for timely genomic analysis in bacterial outbreaks in the near future.
    Public Health Genomics 10/2012; 15(6). DOI:10.1159/000342770 · 2.21 Impact Factor
Show more